Traianos, Emmanuella Young http://orcid.org/0000-0002-4361-7022
,
Locke, James
Lendrem, Dennis http://orcid.org/0000-0001-6268-5509
Bowman, Simon http://orcid.org/0000-0001-9880-9948
Hargreaves, Ben
Macrae, Victoria
Tarn, Jessica Rachael
Ng, Wan-Fai http://orcid.org/0000-0002-5539-388X
Funding for this research was provided by:
Medical Research Council UK (G0800629)
Article History
Received: 4 November 2019
Accepted: 21 January 2020
First Online: 11 February 2020
Compliance with ethical standards
:
: Author Professor Simon Bowman has provided consultancy services in the area of Sjögren’s syndrome for the following companies: Celgene, Eli Lilly, Glenmark, GSK, Medimmune, Novartis, Ono, Pfizer, Takeda, UCB. Author Emmanuella Young Traianos declares that she has no conflict of interest. Author Dr. James Locke declares that he has no conflict of interest. Author Dr. Dennis Lendrem declares that he has no conflict of interest. Author Ben Hargreaves declares that he has no conflict of interest. Author Victoria Macrae declares that she has no conflict of interest. Author Dr. Jessica Rachael Tarn declares that she has no conflict of interest. Author Professor Wan-Fai Ng declares that he has no conflict of interest.
: Research ethics approval was granted by the UK North-West Research Ethics Committee. All procedures involving human participants in this study were performed in accordance with the Newcastle University’s guidelines on the use of humans in research which are based on those established by the HRA’s Research Ethics Service, the 1964 Declaration of Helsinki and its later amendments, and the Human Rights Act (1998).
: Informed consent was obtained from all individual participants included in the study.